Procedure guidelines for radionuclide myocardial perfusion imaging (Adopted by the British Cardiac Society, the British Nuclear Cardiology Society, and the British Nuclear Medicine Society)

Nuclear Medicine Communications

Volumn 24, Issue 10, 2003, Pages 1105-1119

  Anagnostopoulos, C ^a   Harbinson, M ^b   Kelion, A ^b   Kundley, K ^b   Loong, C Y ^b   Notghi, A ^b   Reyes, E ^b   Tindale, W ^b   Underwood, S R ^b   Van Aswegen, A ^b   Hilson, A J W ^b   Metcalfe, M ^b   Nunan, T ^b   Prescott, M ^b   Prvulovich, E M ^b   Tweddel, A C ^b   Vivian, G ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CLINICAL PRACTICE; COMPUTER ASSISTED DIAGNOSIS; CORONARY ARTERY ATHEROSCLEROSIS; EXERCISE TEST; HEART; IMAGE ENHANCEMENT; MEDICAL SOCIETY; METHODOLOGY; PRACTICE GUIDELINE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARD; UNITED KINGDOM;

CORONARY ARTERIOSCLEROSIS; EXERCISE TEST; GREAT BRITAIN; HEART; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RADIOPHARMACEUTICALS; SOCIETIES, MEDICAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84876159813     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006231-200310000-00011     Document Type: Review

References (73)

1. Secretary of State for Health. The new NHS. London: The Stationery Office Ltd, 1997 (Cm 3807).
2. Entrez-PubMed. (Homepage of the PuBMed service of the United States National Library of Medicine, May 2002). Available on-line from URL: http://www.ncbi.nlm.nih.-gov/entrez/query.fcgi
3. Gibbons RJ, Balady GJ, Beasley J, et al. ACC/AHA guidelines for exercise testing. J Am Coll Cardiol 1997; 30: 260-311.
4. Gibbons RJ, Balady GJ, Bricker TJ, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2002; 106: 1883-1892.
5. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 1999; 33: 2092-2097.
6. DePuey EG, Garcia E, Borges-Neto S, et al. Updated imaging guidelines for nuclear cardiology procedures, part 1. J Nucl Cardiol 2001; 8: G1-G58.
7. Strauss HW, Miller DD, Wittry MD, et al. Procedure guidelines for myocardial perfusion imaging 2.0. Society of Nuclear Medicine procedure guidelines manual, 2001-2002.
8. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996; 93: 905-914.
9. Brown KA, Heller GV, Landin RS, et al. Early dipyridamole-(99m) Tc-sestamibi single-photon emission computed tomography imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and post discharge cardiac events: comparison with sub maximal exercise imaging. Circulation 1999; 100: 2060-2066.
10. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update on perioperative cardiovascular evaluation for noncardiac surgery. Circulation 2002; 105: 1257-1267.
11. Heller LI, Cates C, Popma J, et al. Intracoronary Doppler assessment of moderate coronary artery disease. Comparison with thallium-201 imaging and coronary angiography. Circulation 1997; 96: 484-490.
12. Zellweger MJ, Lewin HC, Lai S, et al. When to stress patients after coronary artery bypass surgery? Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: implications of appropriate clinical strategies. J Am Coll Cardiol 2001; 37: 144-152.
13. Allman KC, Shaw LJ, Hachamovitch R, et al. Myocardial viability testing and impact of revascularisation on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002; 39: 1151-1158.
14. Donaldson RM, Raphael M, Radley-Smith R, et al. Angiographic identification of primary coronary anomalies causing impaired myocardial perfusion. Cathet Cardiovasc Diagn 1983; 9: 237-249.
15. Lee YS, Moon DH, Shin JW, et al. Dipyridamole Tl-201 SPECT imaging in patients with myocardial bridging. Clin Nucl Med 1999; 24: 759-764.
16. Fukuda T, Akagi T, Ishibashi M, et al. Non-invasive evaluation of myocardial ischaemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing. Am Heart J 1998; 135: 482-487.
17. Miyagawa M, Mochizuki T, Murase K, et al. Prognostic value of dipyridamole-thallium myocardial scintigraphy in patients with Kawasaki disease. Circulation 1998; 98: 990-996.
18. Rodgers G, Ayanian J, Balady G, et al. ACC/AHA Clinical competence statement on stress testing. Circulation 2000; 102: 1726-1738.
19. Hill J, Timmis A. Exercise tolerance testing. BMJ 2002; 324: 1084-1087.
20. Iskandrian AS, Heo J, Kong B, et al. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989; 14: 1487-1490.
21. Gupta NC, Esterbrooks DJ, Hilleman DE, et al. Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. J Am Coll Cardiol 1992; 19: 248-257.
22. Tawarahara K, Kurata C, Tagushi T, et al. Exercise testing and thallium-201 emission computed tomography in patients with intraventricular conduction disturbances. Am J Cardiol 1992; 69: 97-102.
23. O'Keefe JH, Bateman TM, Barnhart CS. Adenosine thallium-201 is superior to exercise thallium-201 for detecting coronary artery disease in patients with left bundle branch block. J Am Coll Cardiol 1993; 21: 1332-1338.
24. Smits P, Corstens FH, Aengevaeren WR, et al. False-negative dipyridamole thallium-201 myocardial perfusion imaging after caffeine infusion. J Nucl Med 1991; 32: 1538-1541.
25. Böttcher M, Czernin J, Sun KT, et al. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med 1995; 36: 2016-2021.
26. Smits P, Lenders JW, Thien T. Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther 1990; 48: 410-418.
27. Shehata AR, Gillam LD, Mascitelli VA, et al. Impact of acute propanolol administration on dobutamine-induced myocardial ischaemia as evaluated by myocardial perfusion imaging and echocardiography. Am J Cardiol 1997; 80: 268-272.
28. Pennell DJ, Mavrogeni SI, Forbat SM, et al. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol 1995; 25: 1300-1309.
29. Taillefer R, Amyot R, Turpin S, et al. Comparison between dipyridamole and adenosine as pharmacological coronary vasodilators in detection of coronary artery disease with thallium-201 imaging. J Nucl Cardiol 1996; 3: 204-211.
30. Ranhosky A, Kempthorne-Rawson J. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation 1990; 81: 1205-1209.
31. Cerqueira M, Verani M, Schwaiger M, et al. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan multicentre trial registry. J Am Coll Cardiol 1994; 23: 384-389.
32. Hays JT, Mahmarian JJ, Cochran AJ, et al. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol 1993; 21: 1583-1590.
33. Rochmis P, Blackburn H. Exercise tests. A survey of procedures, safety, and litigation experience in approximately 170,000 tests. JAMA 1971; 217: 1061-1066.
34. Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3011 studies over 5 years. J Am Coll Cardiol 1997; 29: 1234-1240.
35. Geleijnse M, Elhendy A, Fioretti P, et al. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 2000; 36: 2017-2027.
36. Dubois-Randé JL, Merlet P, Duval-Moulin AM, et al. Coronary vasodilating action of dobutamine in patients with idiopathic dilated cardiomyopathy. Am Heart J 1993; 125: 1329-1336.
37. Bartunek J, Wijns W, Heyndrickx GR, et al. Effects of dobutamine on coronary stenosis physiology and morphology. Comparison with intracoronary adenosine. Circulation 1999; 100: 243-249.
38. British Cardiac Society Guidelines and Medical Practice Committee, and Royal College of Physicians Clinical Effectiveness and Evaluation Unit. Guidelines for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. Heart 2001; 85: 133-142.
39. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2000 guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2000; 36: 970-1062.
40. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 1999; 34: 890-911.
41. Coma-Canella I. Changes in plasma potassium during the dobutamine stress test. Int J Cardiol 1991; 33: 55-60.
42. Dilsizian V, Rocco TP, Freedman NM, et al. Enhanced detection of ischaemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141-146.
43. van Eck-Smit BL, van der Wall EE, Zwinderman AH, et al. Clinical value of immediate thallium-201 reinjection imaging for the detection of ischaemic heart disease. Eur Heart J 1995; 16: 410-420.
44. Administration of Radioactive Substances Advisory Committee (ARSAC). Diagnostic procedures - adult patients, 2002: 37-39.
45. Hicks RJ. Myocardial perfusion scintigraphy techniques using single photon radiotracers. In: Murray and Ell, eds. Nuclear medicine in diagnosis and treatment. 2nd edn. NY: Churchill Livingstone, 1998: 1333-1351.
46. Rocco TP, Dilsizian V, McKusick KA, et al. Comparison of thallium redistribution with rest 'reinjection' imaging for detection of viable myocardium. Am J Cardiol 1990; 66: 158-163.
47. Maurea S, Cuocolo A, Soricelli A, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995; 36: 1945-1952.
48. Thorley PJ, Bloomer TN, Sheard KL, et al. The use of GTN to improve the detection of ischaemic myocardium using Tc-99m-tetrofosmin. Nucl Med Commun 1996; 17: 669-674.
49. van Dongen AJ, van Rijk PP. Minimizing liver, bowel, and gastric activity in myocardial perfusion SPECT. J Nucl Med 2000; 41: 1315-1317.
50. Hurwitz GA, Clark EM, Slomka PJ, et al. Investigation of measures to reduce interfering abdominal activity on rest myocardial images with Tc-99m sestamibi. Clin Nucl Med 1993; 18: 735-741.
51. Groch MW, Erwin WD. Single-photon emission computed tomography in the year 2001: instrumentation and quality control. J Nucl Med Technol 2001; 29: 12-18.
52. Segall GM, Davis MJ. Prone versus supine thallium myocardial SPECT: a method to decrease artefactual inferior wall defects. J Nucl Med 1989; 30: 548-555.
53. Germano G. Technical aspects of myocardial SPECT imaging. J Nucl Med 2001; 42: 1499-1507.
54. Eisner RL, Nowak DJ, Pettigrew R, et al. Fundamentals of 180-degree acquisition and reconstruction in SPECT imaging. J Nucl Med 1986; 27: 1717-1728.
55. Germano G, Berman DS. Quantitative gated perfusion SPECT. In: Germano Berman, eds. Clinical gated cardiac SPECT. NY: Futura, 1999: 115-146.
56. Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147.
57. van Train K, Folks R, Wong C, et al. Optimization of Tc-MIBI SPEC acquisition and processing parameters: collimator, matrix size and filter evaluation. J Nucl Med 1989; 30: P757 (abstract).
58. Ficaro EP, Fessler JA, Shreve PD, et al. Simultaneous transmission/emission myocardial perfusion tomography. Diagnostic accuracy of attenuation-corrected 99mTc-sestamibi single-photon emission computed tomography. Circulation 1996; 93: 463-473.
59. O'Connor MK, Kemp B, Anstett F, et al. A multicenter evaluation of commercial attenuation compensation techniques in cardiac SPECT using phantom models. J Nucl Cardiol 2002; 9: 361-376.
60. Hendel RC, Corbett JR, Cullom SJ, et al. The value and practice of attenuation correction for myocardial perfusion SPECT imaging: A joint position statement from the American Society of Nuclear Cardiology and the Society of Nuclear Medicine. J Nucl Cardiol 2002; 9: 135-143.
61. DePuey EG. How to detect and avoid myocardial perfusion SPECT artifacts. J Nucl Med 1994; 53: 699-702.
62. Iskandrian AS, Heo J, Nguyen T, et al. Left ventricular dilatation and pulmonary thallium uptake after single-proton emission computed tomography using thallium-201 during adenosine-induced coronary hyperemia. Am J Cardiol 1990; 66: 807-811.
63. Candell-Riera J, Santana-Boado C, Bermejo B, et al. Interhospital observer agreement in interpretation of exercise myocardial Tc-99m-tetrofosmin SPECT studies. J Nucl Cardiol 2001; 8: 49-57.
64. Winzelberg GG. Right ventricular visualization-thallium-201 cardiac imaging. Semin Nucl Med 1982; 12: 301-303.
65. Cerqueira M, Weissman N, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. Circulation 2002; 105: 539-542.
66. Pennell DJ, Prvulovich E. Image Interpretation: nuclear cardiology. London: British Nuclear Medicine Society, 1995: 56-79.
67. Berman DS, Germano G. An approach to the interpretation and reporting of gated myocardial perfusion SPECT. In: Germano and Berman, eds. Clinical gated cardiac SPECT. NY: Futura, 1999: 147-182.
68. Mahmarian JJ, Boyce TM, Goldberg RK, et al. Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischaemic heart disease. J Am Coll Cardiol 1990; 15: 318-329.
69. Pohost GM, Alpert NS, Ingwall JP, et al. Thallium redistribution: mechanisms and clinical utility. Semin Nucl Med 1980; 20: 70-93.
70. Weiss AT, Maddahi J, Lew AS, et al. Reverse redistribution of thallium-201: a sign of non transmural myocardial infarction with patency of the infarct-related coronary artery. J Am Coll Cardiol 1986; 7: 61-67.
71. Araujo W, DePuey EG, Kamran M, et al. Artefactual reverse redistribution pattern in myocardial perfusion SPECT with technetium-99m sestamibi. J Nucl Cardiol 2000; 7: 633-638.
72. Verzijlbergen JF, Vermeersch PH, Laarman GJ, et al. Inadequate exercise leads to sub optimal imaging. Thallium-201 myocardial perfusion imaging after dipyridamole combined with low-level exercise unmasks ischaemia in symptomatic patients with non-diagnostic thallium-201 scans who exercise sub maximally. J Nucl Med 1991; 32: 2071-2078.
73. Hitzel A, Manrique A, Cribier A, et al. Diagnostic value of Tl-201 lung uptake is dependent on measurement method. J Nucl Cardiol 2001; 8: 332-338.